Login / Signup

The Efficacy and Safety of Glucagon-Like Peptide-1 Agonists in a Retrospective Study of Patients With Familial Partial Lipodystrophy.

Maria C Foss-FreitasSalman ImamAdam NeidertAnabela Dill GomesDavid T BroomeElif Arioglu Oral
Published in: Diabetes care (2024)
Our study demonstrates the relative safety and effectiveness of GLP-1RA in patients with FPLD.
Keyphrases
  • randomized controlled trial
  • systematic review
  • rheumatoid arthritis
  • ankylosing spondylitis
  • systemic lupus erythematosus
  • interstitial lung disease
  • systemic sclerosis
  • idiopathic pulmonary fibrosis